IP Verse

Solid Forms Of N-[2,4-Bis(1,1-Dimethylethyl)-5-Hydroxyphenyl]-1,4-Dihydro-4-Oxoquinoline-3-Carboxamide

Patent No. EP1993360 (titled "Solid Forms Of N-[2,4-Bis(1,1-Dimethylethyl)-5-Hydroxyphenyl]-1,4-Dihydro-4-Oxoquinoline-3-Carboxamide") was filed by Vertex Pharmaceuticals on Dec 28, 2006. The application was issued on Feb 8, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GEORG KALHAMMER/STEPHAN TEIPELNov 3, 2017-

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP1993360

VERTEX PHARMACEUTICALS
Application Number
EP06848237A
Filing Date
Dec 28, 2006
Status
Opposition Rejected
Nov 1, 2019
Publication Date
Feb 8, 2017
External Links
Slate, Register , Google Patents